COMPASS Pathways plc (CMPS) to Join NASDAQ Biotechnology Index (NBI)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today its common stock will be added to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 23, 2024.

The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market® (NASDAQ®) that are classified as either biotechnology or pharmaceutical companies and is a modified market capitalization weighted index. The NBI is reconstituted annually in December in accordance with a set of eligibility criteria including minimum market capitalization and average daily trading volume, among other criteria.

To learn more about the NASDAQ Biotechnology Index, visit this link.

You May Also Be Interested In

• SK Hynix picks Nasdaq for U.S. share listing - Reuters
• BioCryst presents HAE treatment data at European allergy meeting
• Avalon Advanced Materials appoints former Citigroup analyst to board